Up to 60% off Profit Pro - Limited Time Offer!
Winter Sale

60% off Profit Pro - Limited Time Offer!

Aligos Therapeutics Inc

Aligos Therapeutics Inc

ALGS · NASDAQ
ALGS · NASDAQ

Next Earnings: 10 Mar 2025

41.14
USD1.874.77%

Analysts Recommendations

Bullish

Strong Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Day Range

38.70USD
41.25USD

52 Week Range

0.35USD
42.95USD

Market Cap

141.15MUSD

About

General Information

Type

Common Stock

Exchange

NASDAQ

Currency Code

USD

Currency Name

US Dollar

Country Name

USA

Country ISO

US

ISIN

US01626L1052

CUSIP

-

Sector

Healthcare

Industry

Biotechnology

Fiscal Year End

December

IPO date

-

Updated At

-

Highlights

PE Ratio

-

PEG Ratio

-

Book Value

15.07

Dividend Share

-

Dividend Yield

-

Earnings Share

-7.25

Wall Street Target Price

103.3333

EPS Estimate Current Year

-10.36

EPS Estimate Next Year

-13.005

EPS Estimate Current Quarter

-2.16

EPS Estimate Next Quarter

-1.49

Most Recent Quarter

-

Profitability

Revenue TTM

5,997,000

Gross Profit TTM

-71,170,000

EBITDA

-92,684,000

Profit Margin

0.00%

Return On Assets TTM

-67.32%

Return On Equity TTM

-146.69%

Revenue Per Share TTM

1.005

Qtly Revenue Growth YOY

-60.80%

Diluted Eps TTM

-7.25

Qtly Earnings Growth YOY

0.00%

Valuation

Trailing PE

0.00

Forward PE

0

Price Sales TTM

23.5364

Price Book MRQ

2.8175

Enterprise Value Revenue

12

Enterprise Value EBITDA

0

Peers analysis

  • BioNTech SE
    BNTXBioNTech SE

    115.38

    1.29%
  • CSL Ltd
    CSLLYCSL Ltd

    88.70

    1.04%
  • Vertex Pharmaceuticals Inc
    VRTXVertex Pharmaceuticals Inc

    409.38

    0.36%
  • Regeneron Pharmaceuticals Inc
    REGNRegeneron Pharmaceuticals Inc

    715.42

    0.13%
  • Alnylam Pharmaceuticals Inc
    ALNYAlnylam Pharmaceuticals Inc

    243.68

    0.09%
  • argenx NV ADR
    ARGXargenx NV ADR

    630.10

    0.02%
  • argenx SE
    ARGNFargenx SE

    630.00

    0.00%
  • CSL Limited
    CMXHFCSL Limited

    173.50

    0.00%
  • UCB SA
    UCBJFUCB SA

    198.28

    0.00%
  • UCB SA ADR
    UCBJYUCB SA ADR

    99.02

    -0.96%